Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) announced its earnings results on Thursday. The specialty pharmaceutical company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. Elite Pharmaceuticals had a positive return on equity of 15.55% and a negative net margin of 8.98%.
Elite Pharmaceuticals Trading Down 4.0 %
Shares of OTCMKTS:ELTP traded down $0.02 during midday trading on Monday, hitting $0.53. 5,052,323 shares of the stock traded hands, compared to its average volume of 798,234. The stock has a market capitalization of $566.23 million, a PE ratio of -53.00 and a beta of 0.27. The business's 50 day moving average is $0.52 and its two-hundred day moving average is $0.45. The company has a quick ratio of 2.42, a current ratio of 3.52 and a debt-to-equity ratio of 0.10. Elite Pharmaceuticals has a one year low of $0.12 and a one year high of $0.75.
About Elite Pharmaceuticals
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Recommended Stories
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
